Bart van Rhijn

Bart van Rhijn

Director of Finance/CFO at NANOBIOTIX

Net worth: 16 M $ as of 2026-05-30

54 year
Health Technology
Consumer Services
Technology Services

Profile

Bart van Rhijn is currently Chief Financial & Business Officer at Nanobiotix SA since 2021.
Formerly, Mr. van Rhijn was Senior Director-Mergers & Acquisitions at Philips Research Laboratories from 2007 to 2010, Head-Finance at Galderma International SAS from 2015 to 2018, Chief Financial Officer at Servier Pharmaceuticals LLC from 2018 to 2021, and Head-Tax at PricewaterhouseCoopers Services BV.
Education includes a graduate degree from the University of Leiden and an MBA from Babson College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 410,747 ( 0.81% ) 16 M $ 2026-05-30

Bart van Rhijn active positions

CompaniesPositionStart
NANOBIOTIX Director of Finance/CFO 2021-05-31

Former positions of Bart van Rhijn

CompaniesPositionEnd
Director of Finance/CFO 2021-04-30
Corporate Officer/Principal 2018-07-31
Corporate Officer/Principal 2010-01-31
Comptroller/Controller/Auditor -
See the detail of Bart van Rhijn's experience

Training of Bart van Rhijn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Health Technology

Consumer Services

Health Technology

Technology Services

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Bart van Rhijn